Recital 11, Regulation (EU) 2020/771

In forcesince 11 Jun 2020

On 24 August 2016, the Authority issued a scientific opinion on the safety of annatto extracts (E 160b) as a food additive [EFSA Journal 2016;14(8):4544.]. As regards the annatto extracts currently authorised the Authority concluded that the safety of their use within the specifications defined in Regulation (EU) No 231/2012 (solvent-extracted bixin and norbixin, alkali-extracted annatto and oil-extracted annatto) could not be assessed due to lack of data, both in terms of identification and toxicological studies. As regards the new annatto extracts and, in particular, aqueous-processed bixin (Annatto E), the Authority could not conclude on its safety due to equivocal genotoxicity results. For the four remaining new extracts (‘solvent-extracted bixin’, ‘solvent-extracted norbixin’, ‘alkali-processed norbixin, acid-precipitated’ and ‘alkali-processed norbixin, not acid-precipitated’), the Authority indicated that they should comply with the specifications recommended in the scientific opinion. Finally, the Authority derived an acceptable daily intake (ADI) of 6 mg bixin/kg body weight (bw) per day and an ADI of 0,3 mg norbixin/kg bw per day. Exposure estimates linked to the proposed uses and use levels for bixin were below the ADI for all population groups and for the two refined exposure scenarios (brand-loyal and non-brand-loyal exposure scenarios). However, for norbixin, those estimates exceeded the ADI at the high level (95th percentile) for infants, toddlers and children in the refined brand-loyal exposure scenario.